Epigallocatechin-3-gallate
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Hal Chapman
Overview
Epigallocatechin-3-gallate is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Epigallocatechin-3-gallate clinical trials
Explore related
Medical disclaimer. This page summarizes research about Epigallocatechin-3-gallate for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.